Published in AIDS Weekly, May 7th, 2001
These data were presented at the International Workshop on HIV Clinical Pharmacology in Noordwijk, The Netherlands, April 2-4, 2001.
"These studies with once-daily Fortovase plus ritonavir are in line with recent changes in U.S. HIV treatment guidelines, which supported the use of such boosted protease inhibitor regimens as a means of possibly simplifying dosing regimens and thus...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.